Inhouse Counsel & Artificial Intelligence: Lawful Deployment & Effective Risk Management

Introduction

Artificial intelligence (AI) promises massive benefits from increased productivity to highly personalised user experience. However, it comes with significant legal, regulatory and ethical challenges. Alongside the EU AI Act’s focus on prohibited uses and the effective management of ’high risk‘ AI, in-house counsel must also get to grips with issues ranging from intellectual property infringements, confidentiality, data protection and legal privilege concerns, supplier due-diligence, hallucinations, bias and discrimination.

For businesses operating across regions and jurisdictions, the global patchwork of laws and regulation presents an increasingly complex challenge.

This webinar highlights the practical issues that in-house counsel should focus on, providing a usable route-map to compliance.

What You Will Learn

This webinar will cover the following:

• Assessing AI risk - unacceptable, high-risk, low or minimal?
• Key points and questions for supplier due diligence - sources of training data and risks of bias, discrimination and the risk of hallucination
• How can you secure appropriate contractual protection? - Warranties and indemnities
• How can you accurately identify and manage intellectual property risks?
• Does your proposed AI project come with confidentiality and legal privilege risks?
• How can you manage internal risks? - Prompts and other user interactions
• Can you meet transparency and explainability requirements?
• How does your AI project come with enhanced data protection risks? - Automated decision-making, employee monitoring, barriers to the exercise of data subject rights
• What are the key governance, reporting and monitoring obligations?

This pre-recorded webinar will be available to view from Monday 30th September 2024

Alternatively, you can gain access to this webinar and 1,700+ others via the MBL Webinar Subscription. Please email webinarsubscription@mblseminars.com for more details.